• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Ayasdi Launches New AI Platform That Turns Health Systems Into AI App Incubators

by HITC Staff 06/21/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Ayasdi Launches New AI Platform That Turns Health Systems Into AI App Incubators

Ayasdi, a provider of machine intelligence software and AI apps, has announced the release of Ayasdi Envision, a new framework enabling health systems to become AI app incubators.  Starting today, health systems will be able to easily build their own apps on top of an enterprise-class Artificial Intelligence platform. The Envision framework will enable healthcare organizations to quickly create and consume intelligent apps that are purpose-built to solve a broad array of clinical and business problems.

“By 2018, Gartner expects most of the world’s largest 200 companies to exploit intelligent apps and utilize the full toolkit of big data and analytics tools to refine their offers and improve customer experience,” per Gartner’s Top 10 Strategic Technology Trends for 2017. “However intelligent apps are not limited to new digital assistants – every existing software category from security tooling to enterprise applications such as marketing or ERP will be infused with AI enabled capabilities.”

Breaking down the barrier between IT analysts and end-users

The new framework democratizes and accelerates the creation of intelligent applications. Designed for iterative development, its collaborative, workflow-oriented approach involves clinical end-users throughout the process, ensuring the requirements of subject-matter experts are met. Analysts, data scientists and IT groups can leverage the AI platform to build business-specific intelligent applications using a pre-built library of UI components. The new web-based framework features a simple user interface that is easy to learn and navigate to make it easy for clinical and financial department users and data analysts to work in lock-step together.

“Ayasdi Envision will transform how intelligent applications are designed, developed and deployed in the enterprise,” said Ronaldo Ama, EVP, Product and Engineering at Ayasdi in a statement. “We’ve made it incredibly simple and natural for technical and non-technical counterparts to interact and collaborate on the development of intelligent applications using a visual, web-based workflow. These applications surface the power of Ayasdi to discover, predict, justify, act and learn on your data.”

 

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI App Incubators, AI in healthcare, Artificial Intelligence, Artificial Intelligence (AI) Software Platform, Artificial Intelligence Companies, Artificial Intelligence in Healthcare, Ayasdi, Machine Learning

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |